We are live on ! Find out more
CASM

CAS Medical Systems, Inc.
CASM

Delisted

CASM was delisted on the 18th of April, 2019.

19 hedge funds and large institutions have $13.9M invested in CAS Medical Systems, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

0% more funds holding

Funds holding: 1919 (0)

9% less capital invested

Capital invested by funds: $15.3M → $13.9M (-$1.43M)

Holders
19
Holders Change
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CASM Hedge Fund Activity: Q4 2016 in Review

19 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems, Inc. (CASM) for Q4 2016, worth a combined $13.9M — down 9.3% from $15.3M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CASM positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $562K. The largest seller was Broadfin Capital, exiting entirely with an estimated $972K sold.

  • 19 institutional investors held CAS Medical Systems, Inc. (CASM) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $13.9M of CAS Medical Systems, Inc. stock for Q4 2016, down 9.3% quarter-over-quarter.
  • 3 funds opened new CAS Medical Systems, Inc. positions in Q4 2016 and 2 closed out, a net change of +1 holder.
  • The largest CAS Medical Systems, Inc. buyer in Q4 2016 was Acuta Capital Partners, an estimated $562K added.
  • The largest CAS Medical Systems, Inc. seller in Q4 2016 was Broadfin Capital, an estimated $972K sold.

Based on aggregated 13F filings for Q4 2016.